We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




BOLD MRI Can Detect Coronary Stenosis at Rest

By MedImaging International staff writers
Posted on 26 Jul 2016
Image: A patient about to undergo an MRI scan (Photo courtesy of MNT).
Image: A patient about to undergo an MRI scan (Photo courtesy of MNT).
A new study suggests that blood oxygen-level dependent (BOLD) magnetic resonance imaging (MRI) can detect myocardial ischemia without inducing cardiac physiological or pharmacological stress.

Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a study to reevaluate data published in 2012 that focused more on segment-based analysis of BOLD, whereas the new analysis focused on whole-slice analysis. In the first study, which included 25 coronary artery disease (CAD) patients and 20 healthy volunteers, the researchers determined the diagnostic performance of stress BOLD imaging in identifying significant CAD.

For the present analysis, resting BOLD signal intensity was first evaluated in the derivation group, and then tested in a separate validation group of 57 patients with suspected CAD referred for diagnostic coronary angiography. The range of BOLD signals at rest for each patient was indexed to create a score that correlated with presence of CAD, with an average index of 22.6% in those with versus 15.4% for those without ischemia. The researchers therefore defined a 16.1% cutoff score that identified ischemia-causing blockages.

Upon validation, the researchers found that the BOLD model could identify blockages with 88% sensitivity, 58% specificity, and 75% overall diagnostic accuracy. It performed similarly for diagnosing anatomically-significant CAD--defined as 50% or greater stenosis--at 82% sensitivity, 61% specificity, and 75% overall diagnostic accuracy. The researchers also concluded that BOLD MRI could perform equally well at stress as at rest. The study was published in the July 2016 issue of JACC: Cardiovascular Imaging.

“Our findings are pertinent to alternative imaging modalities with the potential to identify microvascular heterogeneity, and advance the concept of a functional assessment of CAD being performed at rest,” concluded lead author Jayant Ranjit Arnold, BMBCh, MA, and colleagues. “The inability of resting myocardial blood flow to discriminate the presence of CAD indicates that the favorable diagnostic performance of resting BOLD assessment is not dependent on changes in resting myocardial blood flow.”

BOLD MRI measures the blood oxygen level dependent signal that is associated with changes in blood flow and oxygenation following neural activity. The technique is particularly helpful in neurology for patients with premotor symptoms of Parkinson’s disease (PD) such as frontal executive dysfunction. The neuroimaging provides excellent resolution and diagnostic sensitivity, and can facilitate the diagnosis of other neurodegenerative conditions, including multiple system atrophy, corticobasal degeneration, and progressive supranuclear palsy.

Related Links:
John Radcliffe Hospital


Digital Color Doppler Ultrasound System
MS22Plus
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Post-Processing Imaging System
DynaCAD Prostate
Mammography System (Analog)
MAM VENUS

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.